Showing 1-6 of 48 results
A new collaboration between clinical trial teams in north west London has been announced today (14 September) that aims to improve access to and the quality of clinical research in the region.…
Treating Covid-19 patients who are not critically ill with blood thinning drugs helps reduce the need for organ support and critical care, a recently published study has found.
A new study of cells provides support and scientific validation for the MATIS clinical trial, led by Imperial College London and Imperial College Healthcare NHS Trust.
New findings from the REACT-2 study, a major coronavirus antibody surveillance survey, have shown the impact of England’s vaccination programme on antibodies in the population.
The first trial of a new Covid-19 vaccine technology has shown no short-term safety concerns.
Miss Catherine Rennie, consultant ear nose and throat (ENT) surgeon, has been recognised in this year’s Top 50 Women in Engineering list.
© Copyright 2020 Imperial College Healthcare NHS Trust
